DSpace

About the Bionics Institute

 

Bionics Institute Research Online >
Bionic Hearing >
Bionic Hearing Research Publications >


Title: Pharmacokinetics and tissue distribution of neurotrophin 3 after intracochlear delivery
Authors: Richardson, Rachael
Hu, Qi-Ying
Shi, Fuxin
Nguyen, Trung
Fallon, James
Flynn, Brianna
Wise, Andrew
Keywords: Neurotrophin-3
Cochlea
Drug delivery
Radiolabel
Clearance
Distribution
Pharmacokinetics
Hearing loss
Issue Date: Feb-2019
Publisher: Elsevier B.V.
Citation: Richardson, R. T., Q. Y. Hu, F. Shi, T. Nguyen, J. B. Fallon, B. O. Flynn, and A. K. Wise. 2019. Pharmacokinetics and tissue distribution of neurotrophin 3 after intracochlear delivery. Journal of controlled release : official journal of the Controlled Release Society. 299: 53-63.
Abstract: Neurotrophin therapy has potential to reverse some forms of hearing loss. However, cochlear pharmacokinetic studies are challenging due to small fluid volumes. Here a radioactive tracer was used to determine neurotrophin- 3 retention, distribution and clearance after intracochlear administration. 125I- neurotrophin-3 was injected into guinea pig cochleae using a sealed injection technique comparing dosing volumes, rates and concentrations up to 750 μg/mL. Retention was measured by whole-cochlear gamma counts at five time points while distribution and clearance were assessed by autoradiography. Smaller injection volumes and higher concentrations correlated with higher retention of neurotrophin-3. Distribution of neurotrophin-3 was widespread throughout the cochlear tissue, decreasing in concentration from base to apex. Tissue distribution was nonuniform, with greatest density in cells lining the scala tympani and lower density in neural target tissue. The time constant for clearance of neurotrophin-3 from cochlear tissues was 38 h but neurotrophin-3 remained detectable for at least 2 weeks. Neurotrophin-3 was evident in the semi-circular canals with minor spread to the contralateral cochlea. This study is the first comprehensive evaluation of the disposition profile for a protein therapy in the cochlea. The findings and methods in this study will provide valuable guidance for the development of protein therapies for hearing loss.
URI: http://repository.bionicsinstitute.org:8080/handle/123456789/381
ISSN: 0168-3659
Appears in Collections:Bionic Hearing Research Publications

Files in This Item:

File Description SizeFormat
2019_Richardson_Pharmacokinetics.pdf1.66 MBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2010  Duraspace -